Regulation and supervision of OTC derivatives is still working its way through
Cristiano Zazzara, vice president, head of Application
Specialists (EMEA), S&P Capital IQ
reform of the regulation and supervision of over-the-counter
(OTC) derivatives is still working its way through the
financial system, with loose ends being tidied up and grey
areas being examined.
That said, as the dust begins to settle, the outline of most of
the main changes is clear, thus it is possible to draw some
conclusions about the likely implications of these
This article is available to subscribers and registered users
Please log in to continue reading.
Not yet registered? Take a free trial.
If you have already taken a free trial you
have ongoing access to the analysis section of FOW.com including this story.
Log in using your details below to read.
Already have an account? |